Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
Add more filters










Publication year range
1.
Reumatismo ; 76(1)2024 Mar 22.
Article in English | MEDLINE | ID: mdl-38523583

ABSTRACT

OBJECTIVE: Melorheostosis is a rare, non-hereditary, benign bone disease characterized by abnormal bone growth. Generally, melorheostosis develops during childhood or adolescence and progresses gradually over time. This disease represents a true challenge to the physician because of its variability due to location, extension of the affected bone, and involvement of associated soft tissue. Pain management, physical therapy, and surgery may be recommended, depending on the individual case. This review aims to get an overview of the latest evidence relating to epidemiology, clinical and radiographic characteristics, diagnosis, and possible therapeutic strategies for melorheostosis and describe our experience through a clinical case. METHODS: We designed a comprehensive literature search on melorheostosis in MEDLINE (via Pubmed) up to April 2023 and reviewed reports published in international journals. RESULTS: The purpose is to highlight the importance of a multidisciplinary approach in the management of a rare disease such as melorheostosis. We discuss the role of different physicians, including genetists, rheumatologists, physiatrists, physical therapists, and orthopedic surgeons, in providing accurate diagnoses and effective treatments. We conducted a comprehensive review of the literature on the treatment of melorheostosis to support these findings. In addition, the article presents a case study of a patient suffering from melorheostosis, focusing on difficulties in reaching a correct diagnosis and attempts towards conservative and surgical interventions. The patient underwent hip arthroplasty, and the final result was an improvement in function and a reduction in pain. CONCLUSIONS: Managing melorheostosis can be challenging, and there is no standardized treatment for this condition at the moment.


Subject(s)
Melorheostosis , Adolescent , Humans , Melorheostosis/complications , Melorheostosis/surgery , Melorheostosis/diagnosis , Pain , Pain Management , Treatment Outcome , Rare Diseases
2.
J Plast Surg Hand Surg ; 56(5): 255-260, 2022 Oct.
Article in English | MEDLINE | ID: mdl-34431757

ABSTRACT

The treatment of trapeziometacarpal (TM) osteoarthritis is still debated, as many surgical options are available, and no technique has proven to be superior. Prosthetic treatment in this context has been described since the early 60s. Recently, the use of pyrolytic carbon-based prosthesis has revolutionized arthroplasty surgery in the hand. We performed a retrospective investigation of our surgical management of TM osteoarthritis since 2010 including the study only patients treated with partial trapeziectomy and Pyrodisk implant, with at least 5 years follow-up. After the application of inclusion criteria, 26 patients (6 males and 20 females) were retained. Despite the literature suggesting that implant TM surgery is well suited for older patients, in our experience, the procedure was mainly proposed to the young manual worker, with high demands in terms of thumb strength and stability (mean age of 53 years old, range 37-65). A statistically significant improvement in post-operative DASH, Kapandji and scores was observed. As well, strength measurements, particularly pinch strength and grip strength, increased significantly after the surgery. According to our findings, the Pyrodisk implant provides satisfactory results in terms of thumb strength and stability even in young and active patients and should therefore be considered as a valuable option in selected cases. Meticulous surgical procedure is mandatory in order to avoid complications and should therefore be executed by an expert surgeon. Abbreviation: IV: level of evidence.


Subject(s)
Carpometacarpal Joints , Joint Prosthesis , Osteoarthritis , Trapezium Bone , Adult , Aged , Carbon , Carpometacarpal Joints/surgery , Female , Follow-Up Studies , Humans , Male , Middle Aged , Osteoarthritis/surgery , Range of Motion, Articular , Retrospective Studies , Thumb/surgery , Trapezium Bone/surgery
3.
HIV Med ; 18(10): 764-771, 2017 11.
Article in English | MEDLINE | ID: mdl-28737297

ABSTRACT

OBJECTIVES: Frailty is a predictor of adverse health outcomes and can be measured across the life course, including among people living with HIV. The purpose of this study was to examine two commonly used measures of frailty - the frailty index (FI) and frailty phenotype - to assess common characteristics and to describe associations with multimorbidity, falls, and disability in people aging with HIV. METHODS: This was a cross-sectional observational study including 482 consecutive HIV-infected patients (mean age 53.9 ± SD 6.9 years; 75% male) attending the multidisciplinary metabolic clinic at the University of Modena, Italy. Frailty was measured with the frailty phenotype and a 37-item FI. RESULTS: The mean FI score was 0.28±0.1 and frailty phenotype categories were: 3.1% frail, 51.9% pre-frail, and 45% robust. The duration of antiretroviral therapy was significantly different across levels of frailty as measured by both frailty tools (P < 0.01), but the nadir CD4 count was only significant for the FI (P = 0.01); current CD4 count was not significantly different across frailty levels using either tool. Both frailty measures were associated with multimorbidity; the FI was associated with Instrumental Activities of Daily Living impairment and falls history, whereas the frailty phenotype was not. CONCLUSIONS: The frailty phenotype and the FI demonstrated similar characteristics in patients at a tertiary-level HIV clinic. The FI had a stronger association with age, nadir CD4 count, comorbidities, falls, and disability. Integrating frailty assessments in clinical practice will be crucial for the development of interventions in age-related conditions, including disability and falls, in older persons living with HIV.


Subject(s)
Accidental Falls , Frailty , HIV Infections/complications , HIV Infections/mortality , Adult , Aged , Comorbidity , Cross-Sectional Studies , Female , Humans , Italy/epidemiology , Male , Middle Aged
4.
J Diabetes Res ; 2016: 5281267, 2016.
Article in English | MEDLINE | ID: mdl-26839893

ABSTRACT

This study investigated the effects of the new aldose reductase inhibitor benzofuroxane derivative 5(6)-(benzo[d]thiazol-2-ylmethoxy)benzofuroxane (BF-5m) on the prolongation of cardiac QT interval and increase of coronary perfusion pressure (CPP) in isolated, high glucose (33.3 mM D-glucose) perfused rat hearts. BF-5m was dissolved in the Krebs solution at a final concentration of 0.01 µM, 0.05 µM, and 0.1 µM. 33.3 mM D-glucose caused a prolongation of the QT interval and increase of CPP up to values of 190 ± 12 ms and 110 ± 8 mmHg with respect to the values of hearts perfused with standard Krebs solution (11.1 mM D-glucose). The QT prolongation was reduced by 10%, 32%, and 41%, respectively, for the concentration of BF-5m 0.01 µM, 0.05 µM, and 0.1 µM. Similarly, the CPP was reduced by 20% for BF-5m 0.05 µM and by 32% for BF-5m 0.1 µM. BF-5m also increased the expression levels of sirtuin 1, MnSOD, eNOS, and FOXO-1, into the heart. The beneficial actions of BF-5m were partly abolished by the pretreatment of the rats with the inhibitor of the sirtuin 1 activity EX527 (10 mg/kg/day/7 days i.p.) prior to perfusion of the hearts with high glucose + BF-5m (0.1 µM). Therefore, BF-5m supplies cardioprotection from the high glucose induced QT prolongation and increase of CPP.


Subject(s)
Aldehyde Reductase/antagonists & inhibitors , Benzofurans/pharmacology , Blood Pressure/drug effects , Coronary Circulation/drug effects , Diabetic Cardiomyopathies/prevention & control , Enzyme Inhibitors/pharmacology , Glucose/toxicity , Heart Rate/drug effects , Heart/drug effects , Myocardium/enzymology , Aldehyde Reductase/metabolism , Animals , Cardiotoxicity , Diabetic Cardiomyopathies/enzymology , Diabetic Cardiomyopathies/physiopathology , Forkhead Transcription Factors/metabolism , Heart/physiopathology , Histone Deacetylase Inhibitors/pharmacology , Isolated Heart Preparation , Male , Nerve Tissue Proteins/metabolism , Rats, Sprague-Dawley , Sirtuin 1/antagonists & inhibitors , Sirtuin 1/metabolism , Superoxide Dismutase/metabolism
5.
Neuroscience ; 312: 120-9, 2016 Jan 15.
Article in English | MEDLINE | ID: mdl-26592720

ABSTRACT

Creatine supplementation has been shown to protect neurons from oxidative damage due to its antioxidant and ergogenic functions. These features have led to the hypothesis of creatine supplementation use during pregnancy as prophylactic treatment to prevent CNS damage, such as hypoxic-ischemic encephalopathy. Unfortunately, very little is known on the effects of creatine supplementation during neuron differentiation, while in vitro studies revealed an influence on neuron excitability, leaving the possibility of creatine supplementation during the CNS development an open question. Using a multiple approach, we studied the hippocampal neuron morphological and functional development in neonatal rats born by dams supplemented with 1% creatine in drinking water during pregnancy. CA1 pyramidal neurons of supplemented newborn rats showed enhanced dendritic tree development, increased LTP maintenance, larger evoked-synaptic responses, and higher intrinsic excitability in comparison to controls. Moreover, a faster repolarizing phase of action potential with the appearance of a hyperpolarization were recorded in neurons of the creatine-treated group. Consistently, CA1 neurons of creatine exposed pups exhibited a higher maximum firing frequency than controls. In summary, we found that creatine supplementation during pregnancy positively affects morphological and electrophysiological development of CA1 neurons in offspring rats, increasing neuronal excitability. Altogether, these findings emphasize the need to evaluate the benefits and the safety of maternal intake of creatine in humans.


Subject(s)
CA1 Region, Hippocampal/drug effects , Creatine/pharmacology , Dendrites/drug effects , Long-Term Potentiation/drug effects , Pyramidal Cells/drug effects , Animals , Animals, Newborn , Creatine/administration & dosage , Female , Male , Pregnancy , Rats , Rats, Sprague-Dawley
6.
Mediators Inflamm ; 2014: 857958, 2014.
Article in English | MEDLINE | ID: mdl-25435715

ABSTRACT

The study investigated the effects of the aldose reductase (AR) inhibitor benzofuroxane derivative 5(6)-(benzo[d]thiazol-2-ylmethoxy) benzofuroxane (herein referred to as BF-5m) on the biochemical and tissue alterations induced by endotoxic uveitis in rats. BF-5m has been administered directly into the vitreous, in order to assess the expression and levels of (i) inflammatory markers such as the ocular ubiquitin-proteasome system, NF-κB, TNF-α, and MCP-1; (ii) prooxidant and antioxidant markers such as nitrotyrosine, manganese superoxide dismutase (MnSOD), and glutathione peroxidase (GPX); (iii) apoptotic/antiapoptotic factors caspases and Bcl-xl; (iv) markers of endothelial progenitor cells (EPCs) recruitment such as CD34 and CD117. 5 µL of BF-5m (0.01; 0.05; and 0.1 µM) into the right eye decreased in a dose-dependent manner the LPS-induced inflammation of the eye, reporting a clinical score 1. It reduced the ocular levels of ubiquitin, 20S and 26S proteasome subunits, NF-κB subunits, TNF-α, MCP-1, and nitrotyrosine. BF-5m ameliorated LPS-induced decrease in levels of MnSOD and GPX. Antiapoptotic effects were seen from BF-5m by monitoring the expression of Bcl-xl, an antiapoptotic protein. Similarly, BF-5m increased recruitment of the EPCs within the eye, as evidenced by CD34 and CD117 antibodies.


Subject(s)
Aldehyde Reductase/antagonists & inhibitors , Benzofurans/pharmacology , Enzyme Inhibitors/pharmacology , Uveitis/drug therapy , Animals , Antioxidants/metabolism , Apoptosis/drug effects , Benzofurans/chemistry , Disease Models, Animal , Enzyme Inhibitors/chemistry , Eye/enzymology , Inflammation Mediators/metabolism , Lipopolysaccharides/toxicity , Male , Oxidative Stress/drug effects , Proteasome Endopeptidase Complex/metabolism , Rats , Rats, Sprague-Dawley , Tyrosine/analogs & derivatives , Tyrosine/metabolism , Ubiquitin/metabolism , Uveitis/metabolism , Uveitis/pathology
7.
Clin Hemorheol Microcirc ; 54(1): 109-13, 2013 Jan 01.
Article in English | MEDLINE | ID: mdl-23481597

ABSTRACT

Rett syndrome (RTT) is a post-natal neurological disorder that represents the second most common cause for mental retardation. The presence of cold hands and feet, and blue, a feature frequently observed in these patients, is one of the non-neurological phenotypes that characterizes RTT, up to now not well explained. We have performed videocapillaroscopy in subjects affected by Rett syndrome. We have observed ramified and bushy capillaries, characteristic features of neoangiogenic capillaries, dilated capillaries and an irregular and chaotic microvascular pattern. To quantify these features and to evaluate the microvascular pattern complexity, we have performed a fractal analysis. Fractal dimension and Lempel-Ziv indexes resulted higher in Rett females than in age-matched healthy females (p < 0.001; p < 0.001). Our findings indicate the presence of previously unrecognized microvascular abnormalities in Rett syndrome.


Subject(s)
Rett Syndrome/physiopathology , Adolescent , Case-Control Studies , Child , Child, Preschool , Female , Fractals , Humans , Microcirculation/physiology , Microscopic Angioscopy/methods
8.
Chir Main ; 31(1): 30-3, 2012 Feb.
Article in French | MEDLINE | ID: mdl-22365318

ABSTRACT

INTRODUCTION: Surgery site errors and technical errors in hand surgery are rare and not often published. OBSERVATION: A 46-year-old patient with rhizoarthrosis of the left hand was initially treated by mistake in another center by a scaphoidectomy instead of a trapezectomy. She was seen in consultation 6months later, still suffering from her rhizoarthrosis and with carpal instability, clinically symptomatic and radiologically confirmed. The instability of the wrist was treated by a hamatocapito-lunar arthrodesis and a trapeziometacarpal arthrodesis was performed to treat the rhizoarthrosis. The clinical and radiological results were acceptable. DISCUSSION: Besides the paradigmatic error, this observation confirms that the excision of the scaphoid quickly leads to a destabilization of the wrist, the capitatum no longer maintaining its alignment under the lunatum, and leads to a limitation of the wrist mobility and a loss of strength. The hamato-capito-lunate arthrodesis described in 1997 can treat wrist instability and only the trapeziometacarpal arthrodesis can, in the absence of scaphoid, treat the problem of rhizoarthrosis. CONCLUSION: The authors recommend to always carry out a radiography of the wrist during trapezectomy surgery when there is doubt about the identification of the trapezium.


Subject(s)
Joint Diseases/surgery , Medical Errors , Orthopedic Procedures/methods , Scaphoid Bone/surgery , Trapezium Bone/surgery , Wrist Joint , Female , Humans , Middle Aged
9.
Curr Top Med Chem ; 12(4): 312-20, 2012.
Article in English | MEDLINE | ID: mdl-22204489

ABSTRACT

Indolylglyoxylamides are a class of distinctive benzodiazepine receptor ligands, proposed in the mid-eighties as open analogues of -carbolines. Thorough and long-lasting studies of their structure-activity relationships led to the development of a great deal of derivatives, to satisfy increasingly structural and pharmacophoric requirements of the benzodiazepine binding site in the central nervous system. Efforts to pre-organize their flexible structure in the three-dimensional shape adopted when bound to the receptor led to the identification of two novel classes of rigid ligands, characterized by planar tricyclic heteroaromatic cores: the [1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one and the [1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1,5(6H)-dione. The present review focuses on these selected classes of ligands, whose rational development, in terms of chemical structures and structure-activity relationships, will be fully discussed.


Subject(s)
Amides/chemistry , Anti-Anxiety Agents/chemistry , Glyoxylates/chemistry , Hypnotics and Sedatives/chemistry , Indoles/chemistry , Receptors, GABA-A/metabolism , Amides/pharmacology , Animals , Anti-Anxiety Agents/pharmacology , Binding Sites , Brain/drug effects , Brain/metabolism , GABA-A Receptor Agonists/chemistry , GABA-A Receptor Agonists/pharmacology , GABA-A Receptor Antagonists/chemistry , GABA-A Receptor Antagonists/pharmacology , Glyoxylates/pharmacology , Humans , Hypnotics and Sedatives/pharmacology , Indoles/pharmacology , Ligands , Protein Binding , Protein Subunits/agonists , Protein Subunits/antagonists & inhibitors , Protein Subunits/metabolism , Structure-Activity Relationship , Triazines/chemistry , Triazines/pharmacology , Triazoles/chemistry , Triazoles/pharmacology
10.
Curr Med Chem ; 18(19): 2893-903, 2011.
Article in English | MEDLINE | ID: mdl-21651490

ABSTRACT

Kit is a growth factor receptor of the type III tyrosine kinase family, whose gain-of-function mutations have been identified as driving causes of different kinds of tumours. It thus represents a viable drug target, and the development of Kit inhibitors has been shown to be a promising therapeutic concept. This review will focus on structural and signalling properties of both wild-type and mutant Kit, as well as its role in the development of human cancers. Special attention will be dedicated to gastrointestinal stromal tumours, GISTs. Progress in research on the aetiopathogenesis of GISTs and their therapeutic approaches will be fully discussed, focusing on the latest tendencies for the treatment of these kinds of tumours.


Subject(s)
Antineoplastic Agents/therapeutic use , Gastrointestinal Stromal Tumors/drug therapy , Gastrointestinal Stromal Tumors/enzymology , Protein Kinase Inhibitors/therapeutic use , Proto-Oncogene Proteins c-kit/genetics , Proto-Oncogene Proteins c-kit/metabolism , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Gastrointestinal Stromal Tumors/genetics , Gastrointestinal Tract/drug effects , Gastrointestinal Tract/enzymology , Gastrointestinal Tract/metabolism , Gene Expression Regulation, Neoplastic/drug effects , Humans , Mutation/drug effects , Protein Kinase Inhibitors/chemistry , Protein Kinase Inhibitors/pharmacology , Proto-Oncogene Proteins c-kit/chemistry
11.
Amino Acids ; 40(5): 1385-96, 2011 May.
Article in English | MEDLINE | ID: mdl-21404063

ABSTRACT

Creatine monohydrate (Cr), the most diffuse supplement in the sports industry, is receiving greater attention because of its beneficial effects in a wide number of human degenerative diseases and conditions. These effects can be barely explained on the basis of the sole ergogenic role of the Cr/CrP system. Indeed, a wide number of research articles indicate that Cr is capable of exerting multiple, non-energy related, effects on diverse and relevant cellular targets. Among these effects, the antioxidant activity of Cr emerges as an additional mechanism which is likely to play a supportive role in the Cr-cytoprotection paradigm.


Subject(s)
Antioxidants , Creatine , Animals , Antioxidants/administration & dosage , Antioxidants/metabolism , Antioxidants/pharmacology , Creatine/administration & dosage , Creatine/metabolism , Creatine/pharmacology , Dietary Supplements , Humans , Reactive Oxygen Species/metabolism
12.
Curr Top Med Chem ; 10(10): 976-92, 2010.
Article in English | MEDLINE | ID: mdl-20370657

ABSTRACT

Adenosine is a ubiquitous homeostatic substance which exerts its action by triggering four different cell membrane G protein-coupled receptors, classified as A(1), A(2A), A(2B), and A(3). Being widely distributed and deeply involved in several physiological functions, as well as pathological disorders, these receptors represent an excellent drug target and the development of specific ligands has been tested as a promising therapeutic concept. Among the obtainable ligands, allosteric modulators offer higher advantages with respect to classical orthosteric compounds, as they possible to achieve greater selectivity and better modulatory control at disease mediating receptors. Actually, synergizing with adenosine bound to the primary binding site, these compounds may modify receptor functions through interaction with an additional binding site. As a consequence, their actions depend directly on the release of the endogenous agonist. A number of compound have been developed as effective allosteric modulators. Most of them target adenosine A(1) and A(3) receptor subtypes as, to date, little or no research attempt have been made to improve the field of A(2A) and A(2B) ligands. This review updates literature on the allosteric modulators that has appeared in the last few years, focusing its attention on medicinal chemistry, in terms of chemical structure and structure-activity relationships. This will provide new perspectives on existing data and an exciting starting point for the development of novel and more effective modulators.


Subject(s)
Adenosine/pharmacology , Receptors, Purinergic P1/metabolism , Adenosine/analogs & derivatives , Adenosine/chemistry , Allosteric Regulation/drug effects , Animals , Humans , Ligands , Purinergic P1 Receptor Agonists/metabolism , Structure-Activity Relationship
13.
Arch Ital Biol ; 145(2): 99-110, 2007 May.
Article in English | MEDLINE | ID: mdl-17639782

ABSTRACT

Brain derived growth factor (BDNF) gene of rat has a complex structure: at least four 5' untranslated exons regulated by different promoters and one 3' exon containing the encoding region. BDNF is expressed by skeletal muscles in an activity-dependent manner. In this study, BDNF mRNA was analysed by RT-PCR in the soleus muscle following a single (acute) session of running or a training of five days of running (repetitive exercise). Moreover, the expression of the exons was quantitatively analysed by real time RT-PCR. Finally, muscle BDNF protein level was evaluated by western blotting. BDNF mRNA was found to increase over the second day after acute exercise; on the other hand, two peaks (2 and 24 hours after the last session, respectively) in BDNF mRNA level were found after repetitive exercise, but it was similar to that of controls 6 hours after the last session. BDNF protein level progressively increased also after the mRNA went back to the basal level, so suggesting that it cumulates within the cell after acute exercise, whereas it followed the mRNA level time course after repetitive exercise. These results point to the following conclusions: BDNF mRNA is up-regulated by activity, but this response is delayed to the second day after acute exercise; repetitive exercise transiently depresses the expression of BDNF mRNA, so that the over-expression due to the previous day's exercise completely disappears 6 hours after the last exercise session.


Subject(s)
Brain-Derived Neurotrophic Factor/genetics , Brain-Derived Neurotrophic Factor/metabolism , Gene Expression Regulation/physiology , Muscle, Skeletal/metabolism , Physical Conditioning, Animal/physiology , Alternative Splicing/genetics , Animals , Down-Regulation/physiology , Exercise Test , Male , Protein Isoforms/genetics , Protein Isoforms/metabolism , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Up-Regulation/physiology
14.
Hand Clin ; 19(4): 631-48, vii, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14596554

ABSTRACT

The authors report a simple chart that offers a comprehensive picture of spasticity of the upper limb and provides a more objective method of recording data. Distinction is made between fixed postures and the residual active range of motion at the shoulder and elbow. The presence and function of the muscles can be identified easily on dynamic EMG studies, which are essential for understanding the degree of spasticity and dyssynergy related to a single muscle. When spasticity of the upper arm is managed with a global approach and objectives are defined clearly in advance with the patient and caregivers, treatment of shoulder and elbow deformities can achieve important results for personal hygiene or functional targets.


Subject(s)
Cerebral Palsy/surgery , Elbow/surgery , Shoulder/surgery , Activities of Daily Living , Adolescent , Adult , Aged , Cerebral Palsy/physiopathology , Disability Evaluation , Elbow/physiopathology , Electromyography , Female , Hemiplegia/physiopathology , Hemiplegia/surgery , Humans , Male , Middle Aged , Preoperative Care , Quadriplegia/physiopathology , Quadriplegia/surgery , Rotation , Shoulder/physiopathology , Treatment Outcome
15.
Somatosens Mot Res ; 19(4): 279-85, 2002.
Article in English | MEDLINE | ID: mdl-12590829

ABSTRACT

Primary sensory neurons project to motor neurons directly or through interneurons and affect their activity. In our previous paper we showed that intramuscular sprouting can be affected by changing the sensory synaptic input to motor neurons. In this work, motor axon sprouting within a peripheral nerve (extramuscular sprouting) was induced by nerve injury at such a distance from muscle so as not to allow nerve-muscle trophic interactions. Two different procedures were carried out: (1) sciatic nerve crush and (2) sciatic nerve crush with homosegmental ipsilateral L3-L5 dorsal rhizotomy. The number of regenerating motor axons innervating extensor digitorum longus muscle was determined by in vivo muscle tension recordings and an index of their individual conduction rate was obtained by in vitro intracellular recordings of excitatory postsynaptic end-plate potentials in muscle fibers. The main findings were: (1) there are more regenerated axons distally from the lesion than parent axons proximally to the lesion (sprouting at the lesion); (2) sprouting at the lesion was negatively affected by homosegmental ipsilateral dorsal rhizotomy; (3) the number of motor axons innervating extensor digitorum longus muscle extrafusal fibers counted proximally to the lesion increased following nerve injury and regeneration but this did not occur when sensory input was lost. A transient innervation of extrafusal fibers by gamma motor neurons may explain the increase of motor axons counted proximally to the lesion.


Subject(s)
Motor Neurons/physiology , Nerve Regeneration/physiology , Neuronal Plasticity/physiology , Peripheral Nerves/physiology , Presynaptic Terminals/physiology , Sensory Receptor Cells/physiology , Animals , Excitatory Postsynaptic Potentials/physiology , Functional Laterality/physiology , Ganglia, Spinal/physiology , Male , Motor Endplate/physiology , Muscle, Skeletal/innervation , Nerve Crush , Neural Conduction/physiology , Peripheral Nerve Injuries , Rats , Rats, Sprague-Dawley , Rhizotomy , Sciatic Nerve
16.
Neurosci Lett ; 286(1): 21-4, 2000 May 26.
Article in English | MEDLINE | ID: mdl-10822143

ABSTRACT

Neurogenesis occurs throughout life in mammalian dentate gyrus. The effect of learning on newborn cell survival was studied in rat. Rats were trained on a hippocampus-dependent spatial learning task by using Morris water maze. Neurogenesis was evaluated by 5-bromo-2'deoxyuridine administered before learning. Several newborn cells expressed the immature neuron marker TOAD-64. The main findings were as follows: (1) the survival of newborn cells was enhanced by learning at early stage of differentiation; (2) the newborn cells saved by learning were mainly located in the rostral part of external blade of granule cell layer and (3) there was a correlation between the actual individual learning and newborn cell survival.


Subject(s)
Cell Division/physiology , Cell Survival/physiology , Dentate Gyrus/cytology , Dentate Gyrus/growth & development , Maze Learning/physiology , Neurons/cytology , Neurons/metabolism , Space Perception/physiology , Spatial Behavior/physiology , Age Factors , Animals , Antimetabolites/pharmacology , Biomarkers , Bromodeoxyuridine/pharmacology , Cell Count , Dentate Gyrus/metabolism , Male , Rats , Rats, Sprague-Dawley
17.
Neurosci Lett ; 275(1): 29-32, 1999 Nov 05.
Article in English | MEDLINE | ID: mdl-10554977

ABSTRACT

The control of peripheral structural plasticity of motor neurons by primary sensory neurons was studied in rat extensor digitorum longus (EDL) muscle. Polyinnervation of muscle fibers, sprouting and the motor neuron peripheral field size following L4 dorsal root cutting were evaluated using three different approaches: intracellular recording of end plate potentials, histochemical demonstration of sprouting and polyinnervation and in vivo recording of nerve-evoked twitch. Nodal sprouting was found in rhizotomized rats but not in controls and consistently muscle polyinnervation appeared. The muscle portion innervated by L3 ventral root was relatively reduced and that innervated by L5 was relatively enlarged: a trend to caudal shift of muscle innervation arose in rhizotomized rats. A control of motor neuron plasticity by primary sensory neurons is suggested.


Subject(s)
Motor Neurons/physiology , Neuronal Plasticity/physiology , Neurons, Afferent/physiology , Animals , Excitatory Postsynaptic Potentials , Histocytochemistry , In Vitro Techniques , Male , Muscle, Skeletal/innervation , Rats , Rats, Sprague-Dawley , Rhizotomy
18.
Pharmacopsychiatry ; 32(4): 136-41, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10505483

ABSTRACT

OBJECTIVE: Open studies and case observations have suggested that gabapentin may be effective in the treatment of bipolar disorder. However, the adjunctive use of the drug in bipolar mixed states has not been specifically addressed before. METHODS: Twenty-one patients with bipolar I mixed episodes as defined by Diagnostic and Statistical Manual of Mental Disorders (Revised) (DSM-III-R), who were admitted to the outpatient department at the Psychiatry Clinic of the University of Pisa, were treated adjunctively with gabapentin for a period of eight weeks. All patients had been resistant to therapeutic levels of standard mood stabilizers, and had a mean clinical global impression (CGI) of 5.2+/-0.8 when entering the study. Gabapentin treatment was started at 300 mg/day and increased up to 2000 mg/day. Patients were evaluated using the Hamilton Rating Scale for Depression (HRSD), the Young Mania Rating Scale (YMRS), and CGI. Patients with final CGI scores of 1 or 2 were regarded as responders. RESULTS: Only one patient had to interrupt the drug treatment, due to irritability and ataxia. Negative interactions between gabapentin and concomitant psychotropic medications were not observed. The condition deteriorated in only one patient (final CGI = 5). Ten patients were regarded as responders: four showed marked improvement (CGI = 1), and six had moderate improvement (CGI = 2). The mean dose of gabapentin at week 8 was 1130 mg (range 600-2000 mg). The mean final CGI score for all patients (responders and nonresponders combined) was 3.7+/-1.1 (the mean change in CGI was significant, t=6.1, P<0001). The reduction in the mania score was minimal and statistically insignificant. However, the mean HRSD score showed a statistically significant reduction from 18.2 to 10.6 (t=5.73, P<0.0001), irrespective of the baseline severity of the mania. All but one of the responders maintained these therapeutic improvements over 4-12 months, in most cases requiring less concomitant antidepressant and neuroleptic medications. CONCLUSIONS: These results show that gabapentin appears to be potentially useful in the adjunctive treatment of drug-resistant bipolar mixed states, and that it was particularly effective in relation to depressive symptomatology.


Subject(s)
Acetates/therapeutic use , Amines , Antimanic Agents/therapeutic use , Bipolar Disorder/drug therapy , Cyclohexanecarboxylic Acids , gamma-Aminobutyric Acid , Adjuvants, Pharmaceutic/therapeutic use , Adult , Aged , Analysis of Variance , Antidepressive Agents/therapeutic use , Drug Resistance , Drug Therapy, Combination , Female , Gabapentin , Humans , Male , Middle Aged , Treatment Outcome
19.
J Submicrosc Cytol Pathol ; 31(1): 31-40, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10363353

ABSTRACT

The role of N-methyl-D-aspartic acid receptors (NMDARs) of glutamate on neuritogenesis was studied in cultured neurons of chick embryo spinal cord using the NMDAR non-competitive antagonist dizocilpine maleate (MK-801). No cell population was fully prevented from neuritogenesis by MK-801. Different aspects of neuritogenesis were quantitatively evaluated. Neurite initiation, elongation and branching were depressed by MK-801. Inhibition was dose-dependent and reversible. A loss of responsiveness of neuritogenesis to MK-801 was found during the second day of treatment at a concentration of 10 microM, but not at higher concentrations. Our findings support the idea that Ca2+ influx through NMDAR associated channels is one of the possible triggers of a cascade resulting in neuritogenesis. The effects of NMDAR blocking on neuritogenesis occurred before synaptogenesis, suggesting a role of excitatory aminoacids in neuron morphological differentiation at early stages of development. Scanning electron microscopy confirmed a reduction in neurite tree complexity in MK-801 treated cells and showed a production of filopodium-like processes in some of these cells.


Subject(s)
Dizocilpine Maleate/pharmacology , Neurites/physiology , Neurons/cytology , Receptors, N-Methyl-D-Aspartate/physiology , Spinal Cord/cytology , Animals , Calcium/metabolism , Cells, Cultured , Chick Embryo , Microscopy, Electron, Scanning , Neurites/drug effects , Neurites/ultrastructure , Neurons/drug effects , Neurons/physiology , Receptors, N-Methyl-D-Aspartate/drug effects , Spinal Cord/physiology
20.
Neuroscience ; 84(1): 151-61, 1998 May.
Article in English | MEDLINE | ID: mdl-9522370

ABSTRACT

In partially denervated skeletal muscle, spared motor fibres sprout, enlarging motor unit size. Neuritogenesis and sprouting are known to depend on the synaptic input to the neurons. This suggests that spared motoneuron reaction to partial muscle denervation might be controlled by primary sensory neurons which directly or indirectly project to motoneurons. In two groups of rats, different surgical procedures were carried out: partial denervation of the extensor digitorum longus muscle without or with homolateral dorsal rhizotomy. Spared motoneuron peripheral field was evaluated by nerve-evoked tension measures. Following partial muscle denervation, spared motoneurons enlarged their projection peripheral field five to six times, innervating most of the denervated portion of the muscle. When dorsal rhizotomy was carried out together with partial denervation, the enlargement of the motoneuron's peripheral field occurred later; however, the peripheral field size was the same or greater than that found in partially denervated muscles without dorsal rhizotomy in the long term. Excitatory postsynaptic potential recordings at neuromuscular junctions consistently showed that innervation of denervated muscle cells by spared motoneurons was impaired when the dorsal roots were cut. Finally, in both groups of operated rats an increase in motor unit number occurred early after surgery, anticipating a process normally occurring in the same age range. These findings are consistent with the idea that sensory input trans-synaptically controls motoneuron peripheral field size.


Subject(s)
Denervation , Motor Neurons/cytology , Rhizotomy , Animals , Cell Size/physiology , Evoked Potentials, Motor/physiology , Male , Motor Endplate/physiology , Motor Neurons/physiology , Neuromuscular Junction/physiology , Rats , Rats, Sprague-Dawley , Synapses/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...